It has been found that plasma FCN2 expression was decreased in patients with pathological obesity and negatively correlated with the stage of liver fibrosis in patients with non-alcoholic fatty liver disease [66]. The gene discussed is FCN2; the disease is metabolic dysfunction-associated steatotic liver disease.